Guidelines for immunizations and cancer screening recommendations are constantly in flux as new data emerges. This session will review some current recommendations for vaccinations and cancer screening in children and adults in addition to controversies related to these recommendations.
This activity will review the current recommendations for screening (and the evidence behind them) for women-specific cancers. Dr. Friedman from the David Geffen School of medicine at UCLA will discuss up to date recommendations for screening for cervical, breast and ovarian cancers.
In this activity, Daniel Dunham, MD, reviews the pros and cons of screening for cancer, including what characteristics constitute a good screening test. He also discusses screening tests for some common cancer types and the current evidence for or against them.
This talk will review the latest epidemiology of the HIV epidemic in New York. The 2015 update of the Department of Health and Human Services guidelines for first-line treatment regimens will be discussed, and a brief update of the latest data on treatment as prevention will be presented. The latest data addressing the advantages of the early initiation of antiretrovirals will also be presented. Finally, Dr. Scherer will discuss pre-exposure prophylaxis, or PrEP, and will provide practical guidance for the provision of PrEP in primary care practice.
In this activity, Lowell Schnipper, the Theodore and Evelyn Berenson Professor of Medicine at Harvard Medical School, uses several brief cases to highlight the appropriate follow-up and surveillance for patients following primary treatment for breast cancer and colorectal cancer.
In this activity, Dr. Dumanian will discuss the pathophysiology and symptoms of carpal tunnel syndrome and provide with the know-how to diagnose this condition in patients. Dr. Dumanian will also outline various treatment options, both surgical and non-surgical for the management of carpal tunnel syndrome.
Dr. Galluzzi will discuss the best approaches for screening seniors and the elderly for cancers and other diseases. She will explain the cost-benefit analyses a physician should employ before ordering screening tests in their geriatric patient population and discuss generating a practical strategy for determining the stopping age for cancer screening.
Colorectal cancer (CRC) is the 3rd most common cancer among men and women. The incidence is declining in large part due to increased screening and the detection and removal of pre-cancerous polyps. This activity will discuss the various options for screening for CRC and polyps, including advantages and limitations of different methods. Dr. Ghassemi will also discuss how to establish surveillance intervals based on findings at the index examination. The activity will focus on colonoscopy, which is considered the gold standard for screening, and the discussion will include potential reasons for missed polyps/interval cancers and quality indicators for colonoscopy. Newer screening methods, including stool DNA testing and colon capsule screening, will also be described.
In this activity, Dr. Martin will review the latest guidelines as well as the rationale and controversies in screening and prevention. General principles and specific topics including colon, breast, cervical, lung and prostate cancer will be explored. Tips for counseling patients and selecting patients will also be reviewed. He will further discuss relevant vaccinations and cardiovascular screening.
Join us as we discuss HPV vaccination and the growing evidence of the benefits to those who receive the vaccine and the protection of those who are not vaccinated.
Vitamin D and a variety of related conditions are ever present in the medical and lay literature. This activity will review the basics of Vitamin D metabolism, and will discuss what is known and not known about when to test and how to treat Vitamin D deficiency. Clinical outcomes discussed here include, cardiovascular disease, cancer and all cause mortality.
In the Unites States, it is estimated that there are 1.2 million persons living with HIV. This program will discuss appropriate screening patients for HIV infection and how to recognize signs and symptoms of acute retroviral syndrome. Treatment will also be discussed along with what factors influence the selection of an antiretroviral regimen and when pre-exposure prophylaxis is indicated.